Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Exactly . Unless pps goes up enough and have a plan after uplist that must be work out, then ask investors to r/s immediately. If so, I believe all shareholders would be happy to follow and new capital will join in.
2022 Financial Results Highlighted by 5% Growth in Revenue to $10.1 Million, but pps down to 2s ! All because the R/S. And we should know that almost all recently r/s companies' pps are down more than half even after uplist, so if you have no plan, please dont r/s !
They have said no , so cancel the r/s is the only choice to let the pps up and to wait for the better WH leaders. Until then we can reinstate r/s or whatever is the best.
Can we also for sale if someone offers good price ? A 40M+ annual revenue should at least three times current share price worth. I think it should be an option for all.
Yep, especially those need to R/S to qualify for uplist most drop more than 60%. Thats why if we are not engage any possible M/A, we should not rush to uplist.
Yep, many saying didnt get the answers although they acted like they did.
Before we insist to cancel the RS, we should see what the uplist update CEO will say. Again , if no meaningful plan to be benefited, then they should cancel the big R/S immediately .
From the Q1 report we can see RXMD still in progress. If today PR provides some upbeat info, then all have to do just wait...
Chairman and CEO, Alan Jay Weisberg, stated, “We are looking forward to providing our shareholders with our first quarter results, Company’s vision for the rest of 2022, and an update regarding our progress towards uplisting to Nasdaq.”
I think the most we want to know should be covered.
Every body knows that big R/S should be cancelled if Jay has no plan and not sure after R/S where we go . Hopefully he does have a plan and will lead us to the promising land.
Some say is right , how come no shrimp to distribute ??
How come revenue $38.9M , margin 26% , but the ebitda was only $0.02M ? How can they make profit if less tda ? If almost $40M revenue cant make some profit where is the major cost ? can they fix the hole ?
What makes you worry about as a 40M revenue OTC company and is expanding to money maker area ??? under 3s even no body wants ? I think we better make more $$ then buy back shares before to think about R/S to uplist !
Thats right, R/S is harmful to shareholders unless they have a plan, so far we dont see any. Better wait and see to add or ...
Got it, thank you !
If what you said is true then the 10M offering should have no negative effect. And the so called dilution is minimum.
"This prospectus relates to the sale by Progressive Care Inc., a Delaware corporation (the “Company”) of approximately $10,000,000 of units of securities (the “Units”) at an offering price of $ per Unit....."
After uplist then sell more shares ? at what price ??
Seems they are , so we still have hope. Lets wait it out see if we have the chance to do like 1 for 20 or 1 for 25. Anyway, after the R/S, we can see clearly if RXMD is truly undervalue.
if so at least is better than 150 for 1, but how can we get it to $0.10 ? as you know they always in quiet period.
Yep, pps low is NOT because the company no good, it will be ok after the hair cut. ( could be a big drop when announcement of 150 for 1 R/S ).
Me too. hearsay oversea main business of CX Network is blooming, and here not too many shareholders , so even a small good news can makes it fly.
The better way is to postpone or cancel the R/S plan . If company is growing , stay in OTC still fine. Lots OTC companies have better chance to uplist than RXMD still stay in OTC , their pps much higher than 0.03 ...
Every one is waiting for the big R/S finish first, then to see if afterward we have a plan or are heading for better revenue or anything better when in upper market.
Wow, same question, is its revenue will be more than double again ? We should hold tight for better future.
Yep, well said . I believe thats what people think and see too.
Normally no companies wait that long to uplist if they have the power to do so because their goal is to uplist regardless the r/s ratio, besides that as a whole how many divided technically no different.
Unless Jay gives us some very exciting news , otherwise no body will touch it. Right ?
No matter how good it looks, you have to wait for big R/S finish. It may be 150 for 1 ?
The problem is that big R/S is coming, we have been warned that if you are smart , you better wait for the big drop after R/S and then buy as many as you want.
Dont underestimate sleepy Jay, he may cooking something to surprise you all !
As long as the big R/S on its way even God feels difficult ...
Seems like uplist soon, but 1 for 150 R/S is no good, we better wait for few months later. Besides that most recently r/s for uplist companies see their pps down from 45% to 90% which we should be avoided .
How about $15 first ? Haha....
OTC market die out not only just Covid, but also govt attack . Dont you see that many tickets force to disappear ?
The CC not bad, but feel lots uncertainty.
It shouldnt be that way, but it is, just unbelievable. Somehow no body knows it ends up like this.
Haha .." You get back on the horse and keep going " i like that. Sadly there are many on the horse have to keep going, otherwise lose a lot.
Yep, they should. If possible, they should tell the public what they are going to do after the " necessary " R/S uplist.
Your questions are real questions, let see what they say . Thank you !
Sorry, not understand what you mean. May be elites do and let them reply you.
That just some of opinion , we should see the facts. Any example ?